KEGG   DISEASE: Sclerosteosis
Entry
H00486                      Disease                                
Name
Sclerosteosis
Description
Sclerosteosis is rare sclerosing bone dysplasias inherited in an autosomal recessive manner. The main clinical features are enlargement of the jaw and facial bones, which can lead to secondary findings such as facial distortion, increased intracranial pressure often resulting in headaches, and entrapment of the cranial nerves. Other findings include syndactyly and tall stature. This disease is due to loss-of-function mutations in the SOST gene, a protein that binds to LRP5/6 and antagonizes Wnt signaling. Recently, mutations in the LRP4 gene, coding for a Wnt signaling coreceptor, have been found in patients with sclerosteosis.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  Multiple developmental anomalies or syndromes
   LD24  Syndromes with skeletal anomalies as a major feature
    H00486  Sclerosteosis
Pathway-based classification of diseases [BR:br08402]
 Signal transduction
  nt06505  WNT signaling
   H00486  Sclerosteosis
Pathway
hsa04310  Wnt signaling pathway
Network
nt06505 WNT signaling
Gene
(SOST1) SOST [HSA:50964] [KO:K16834]
(SOST2) LRP4 [HSA:4038] [KO:K20051]
Other DBs
ICD-11: LD24.1Y
ICD-10: Q78.8
MeSH: C537525
OMIM: 269500 614305
Reference
  Authors
Mason JJ, Williams BO
  Title
SOST and DKK: Antagonists of LRP Family Signaling as Targets for Treating Bone Disease.
  Journal
J Osteoporos 2010:460120 (2010)
DOI:10.4061/2010/460120
Reference
PMID:20473488 (SOST1)
  Authors
Moester MJ, Papapoulos SE, Lowik CW, van Bezooijen RL
  Title
Sclerostin: current knowledge and future perspectives.
  Journal
Calcif Tissue Int 87:99-107 (2010)
DOI:10.1007/s00223-010-9372-1
Reference
PMID:26751728 (SOST2)
  Authors
Fijalkowski I, Geets E, Steenackers E, Van Hoof V, Ramos FJ, Mortier G, Fortuna AM, Van Hul W, Boudin E
  Title
A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone.
  Journal
J Bone Miner Res 31:874-81 (2016)
DOI:10.1002/jbmr.2782
LinkDB

» Japanese version

KEGG   DISEASE: Cenani-Lenz syndactyly syndrome
Entry
H00853                      Disease                                
Name
Cenani-Lenz syndactyly syndrome
Description
Cenani-Lenz syndactyly syndrome (CLSS) is an autosomal-recessive congenital malformation syndrome characterized by syndactyly and/or oligodactyly and kidney anomalies. The cause of CLSS is LRP4, a low-density lipoprotein receptor that modulates Wnt signaling.
Category
Congenital malformation
Brite
Human diseases in ICD-11 classification [BR:br08403]
 20 Developmental anomalies
  Multiple developmental anomalies or syndromes
   LD26  Syndromes with limb anomalies as a major feature
    H00853  Cenani-Lenz syndactyly syndrome
Pathway-based classification of diseases [BR:br08402]
 Signal transduction
  nt06505  WNT signaling
   H00853  Cenani-Lenz syndactyly syndrome
Network
nt06505 WNT signaling
Gene
LRP4 [HSA:4038] [KO:K20051]
Other DBs
ICD-11: LD26.2
ICD-10: Q78.4
MeSH: C538150
OMIM: 212780
Reference
  Authors
Li Y, Pawlik B, Elcioglu N, Aglan M, Kayserili H, Yigit G, Percin F, Goodman F, Nurnberg G, Cenani A, Urquhart J, Chung BD, Ismail S, Amr K, Aslanger AD, Becker C, Netzer C, Scambler P, Eyaid W, Hamamy H, Clayton-Smith J, Hennekam R, Nurnberg P, Herz J, Temtamy SA, Wollnik B
  Title
LRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome.
  Journal
Am J Hum Genet 86:696-706 (2010)
DOI:10.1016/j.ajhg.2010.03.004
Reference
  Authors
Karner CM, Dietrich MF, Johnson EB, Kappesser N, Tennert C, Percin F, Wollnik B, Carroll TJ, Herz J
  Title
Lrp4 regulates initiation of ureteric budding and is crucial for kidney formation--a mouse model for Cenani-Lenz syndrome.
  Journal
PLoS One 5:e10418 (2010)
DOI:10.1371/journal.pone.0010418
LinkDB

» Japanese version

DBGET integrated database retrieval system